Results 11 to 20 of about 1,139,909 (203)

Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I [PDF]

open access: yesJournal of Experimental & Clinical Cancer Research, 2011
Background This study aimed to investigate the molecular structural relationship between cell adhesive molecule CD44 and Lewis y antigen, and determine the effects of Lewis y antigen on CD44-mediated adhesion and spreading of ovarian cancer cell line RMG-
Liu Juanjuan   +8 more
doaj   +2 more sources

Role of extended red cell phenotyping in management of patient with multiple antibodies and their utility in development of indigenous cell panels for antibody screening

open access: yesGlobal Journal of Transfusion Medicine, 2020
Background and Objectives: The frequencies of clinically significant blood groups antigens (Rh, Duffy, Kell, Kidd, MNS, P and Lewis) should be known to BTS to manage patients with clinically significant antibodies.
Ripal J Shah   +4 more
doaj   +1 more source

Supplementary Table 4 from Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype

open access: yes, 2023
Table S4 presents adjusted associations of ABO blood group alleles and pancreatic cancer risk by Lewis antigen and interactions between ABO blood group alleles and Lewis antigen.
Chen Yuan (14962731)   +6 more
core   +2 more sources

Lipopolysaccharide O-antigen profiles of Helicobacter pylori strains from Southwest China

open access: yesBMC Microbiology, 2023
Background Helicobacter pylori lipopolysaccharide (LPS) structures vary among strains of different geographic origin. The aim of this study was to characterize the LPS O-antigen profiles of H.
Xiaoqiong Tang   +7 more
doaj   +1 more source

Food to Fuel: Biodiesel Processing for Campus and Community Use [PDF]

open access: yes, 2022
The Come Clean, Go Green competition is a program dedicated to making Lewis a more sustainable campus with ideas from Lewis Students across all disciplines.
Lewis University
core   +1 more source

Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway

open access: yesJournal of Experimental & Clinical Cancer Research, 2009
Background Lewis y antigen is difucosylated oligosaccharide and is carried by glycoconjugates at cell surface. Elevated expression of Lewis y has been found in 75% of ovarian tumor, and the high expression level is correlated to the tumor's pathological ...
Cong Jianping   +9 more
doaj   +1 more source

A changing gastric environment leads to adaptation of lipopolysaccharide variants in Helicobacter pylori populations during colonization. [PDF]

open access: yesPLoS ONE, 2009
The human gastric pathogen Helicobacter pylori colonizes the stomachs of half of the human population, and causes development of peptic ulcer disease and gastric adenocarcinoma. H. pylori-associated chronic atrophic gastritis (ChAG) with loss of the acid-
Anna Skoglund   +5 more
doaj   +1 more source

Helicobacter pylori lipopolysaccharide is synthesized via a novel pathway with an evolutionary connection to protein N-glycosylation. [PDF]

open access: yesPLoS Pathogens, 2010
Lipopolysaccharide (LPS) is a major component on the surface of Gram negative bacteria and is composed of lipid A-core and the O antigen polysaccharide.
Isabelle Hug   +5 more
doaj   +1 more source

Is there a link between the lipopolysaccharide of Helicobacter pylori gastric MALT lymphoma associated strains and lymphoma pathogenesis? [PDF]

open access: yesPLoS ONE, 2009
The aim of this study was to investigate the Lewis antigen expression in Helicobacter pylori gastric MALT lymphoma associated strains in comparison to chronic gastritis only strains.
Philippe Lehours   +4 more
doaj   +1 more source

Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29. [PDF]

open access: yesPLoS ONE, 2013
Several monoclonal antibodies (mAbs) recognising Lewis(y), such as BR96, have reached the clinic but have failed to show good anti-tumour responses with an acceptable level of toxicity. No Lewis(b) mAbs have been trialled in patients.
Philip Noble   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy